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Background: The morphogenesis of the cerebral cortex depends on the precise control of gene expression during
development. Small non-coding RNAs, including microRNAs and other groups of small RNAs, play profound roles in
various physiological and pathological processes via their regulation of gene expression. A systematic analysis of
the expression profile of small non-coding RNAs in developing cortical tissues is important for clarifying the gene
regulation networks mediating key developmental events during cortical morphogenesis.
Results: Global profiling of the small RNA transcriptome was carried out in rat cerebral cortex from E10 till P28
using next-generation sequencing technique. We found an extraordinary degree of developmental stage-specific
expression of a large group of microRNAs. A group of novel microRNAs with functional hints were identified, and
brain-enriched expression and Dicer-dependent production of high-abundant novel microRNAs were validated.
Profound editing of known microRNAs at “seed” sequence and flanking sequence was observed, with much higher
editing events detected at late postnatal stages than embryonic stages, suggesting the necessity of microRNA
editing for the fine tuning of gene expression during the formation of complicated synaptic connections at
postnatal stages.
Conclusion: Our analysis reveals extensive regulation of microRNAs during cortical development. The dataset
described here will be a valuable resource for clarifying new regulatory mechanisms for cortical development and
diseases and will greatly contribute to our understanding of the divergence, modification, and function of
microRNAs.
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The mammalian cerebral cortex contains a large number of
neurons of different phenotypes arranging in a stereotypical
laminar pattern [1]. A series of sequential cellular events
happen during cortical development, including neural
progenitor proliferation, cell fate specification, neuronal mi-
gration, neurite outgrowth and pathfinding, and eventually
the formation and plastic modulation of synaptic connec-
tions [2]. The happening of all these developmental events
depends on the precise spatial and temporal control of gene* Correspondence: yuanxb@ion.ac.cn
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reproduction in any medium, provided the orexpression in the cell. Extensive studies have been carried
out to clarify the role of transcription factors, including
activators and repressors, in the regulation of gene tran-
scription during these developmental events. In addition to
transcriptional regulation, various types of small non-
coding RNAs in the cell have been shown to play significant
roles in the control of gene expression during physiological
and pathological processes [3], largely increasing the com-
plexity and flexibility of the gene regulatory network.
MicroRNAs (miRNAs) are a group of most extensively
studied small RNAs of around 18–24 nucleotide (nt) with
the typical stem-loop structure [4]. Most mature miRNAs
directly interact with a group of messenger RNAs (mRNAs)
and suppress their expression either by guiding the cleavage
of the target mRNAs or by inhibiting their translation upon
imperfect base pairing to mRNA’s 3′- untranslated region
(3′-UTR) [4]. Interestingly, some mature miRNAs can. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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sequence, a process known as miRNA editing, which fur-
ther increases the complexity of gene regulation [5]. In
addition to miRNAs, other classes of small RNAs, including
repeat associated small interference RNA (rasiRNA), PIWI-
interacting RNA (piRNA), and small RNAs derived from
transfer RNA (tRNA), ribosomal RNA (rRNA), small
nucleolar RNA (snoRNA), small nuclear ribonucleic acid
RNA (snRNA), small cytoplasmic RNA (scRNA), and signal
recognition particle RNA (srpRNA), also play constitutive
or regulatory functions in various cellular events.
A number of brain miRNAs appear to be developmen-
tally regulated, with high expression in neural progeni-
tors but not in differentiated neurons, or vice versa [6],
suggesting that they may function at different stages of
neuronal development [7]. As well characterized exam-
ples, miR-9 has been shown to regulate embryonic
neurogenesis by targeting the transcription factor TLX
[8]; miR-219 [9] and miR-338 [10] have been identified
as regulators of oligodendrocyte differentiation; miR-124
have been shown to promote neuronal differentiation
and regulate adult neurogenesis [11, 12]; and miR-134
have been shown to regulate dendritic spine morphology
through inhibiting the local translation of Limk1 [13].
Links between miRNA dysfunction and neurological
diseases have become more and more apparent. For ex-
ample, mutation in the seed region of miR-184 causes
familial keratoconus with cataract [14] and mutations in
the seed region of miR-96 are responsible for nonsyn-
dromic progressive hearing loss [15]. Variation in the
miR-433 binding site of FGF20 confers risk for Parkin-
son diseases by up-regulation of α-Synucein [16]. Inter-
ference of miRNA biogenesis by disrupting the miRNA
processing enzyme Dicer in the nervous system has pro-
vided the evidences that miRNAs are essential for the
development of the nervous system [17–20]. Conditional
knock-out of Dicer in the mouse telencephalon resulted
in a size reduction of the forebrain, likely caused by
apoptosis of differentiating neurons [20]. Similar neur-
onal death was observed when Dicer was inactivated
postnatally in the cerebellum [17] or in dopaminergic
neurons in the midbrain [19]. These findings are consist-
ent with an important role of miRNAs in regulation of
cell proliferation, survival, and differentiation in develop-
ing brain. However, which miRNAs are expressed at dif-
ferent developmental stages and how various miRNAs
are engaged in the regulation of each developmental
event remain largely unknown.
Recently, next-generation sequencing has emerged as
a powerful tool for clarifying the expression profile of
small RNAs. The advantages of the massive parallel se-
quencing technique lie in its unbiased high-throughput
detection of small RNAs at a genome-wide scale, even
for low-abundance transcripts, and in its unparalleledability in identifying novel RNA transcripts and modifi-
cation of RNAs such as RNA editing. Although the
next-generation sequencing had started to be used to
examine the brain transcriptome [21], a systematic ana-
lysis of miRNAs in developing brain using this new
high-throughput method is largely lacking.
In the present study, we applied the next-generation
sequencing technique to carry out a systematic analysis
of miRNAs isolated from rat neocortex of many devel-
opmental stages. In addition to the demonstration of dy-
namic and stage-specific expression of a large group of
known miRNAs, we identified a group of novel miRNA
candidates in rat cortex with functional hints. Interest-
ingly, we observed profound nucleotide editing of “seed”
and flanking sequences of miRNAs during cortical devel-
opment. The dataset described here will be a valuable
resource for clarifying new regulatory mechanisms for
cortical development and disease and will greatly con-
tribute to our understanding of the divergence, modifi-
cation, and function of miRNAs.
Results
Overall assessment of different groups of small RNAs
As shown in the work flow (Figure 1A), RNA samples
were extracted from rat cortical tissues of eight develop-
mental stages (E10-P28). A RNA integrity number (RIN)
was evaluated to monitor the general quality of extracted
RNA samples [22]. As shown in Figure S1, RIN of all
samples are ≥8.4, indicating high quality and low degrad-
ation of these samples [22]. RNA samples were size-
selected (10–30 nt) and sequenced by Solexa technique
[23]. Two independent P0 samples were assayed (P0 and
P0’, biological replicates) in order to evaluate the
reproducibility of the experimental procedures. Each
sample was sequenced twice (technical replicates) and
results were averaged to reduce experimental errors. We
obtained approximately 20 million total reads for each
sample after removal of low quality reads and contami-
nants (Table S1, see methods), with the peak length of
each sample at about 20–22 nt (Figure S2). Small RNA
reads >18 nt were annotated based on their sequences,
and their relative abundances were determined by their
counts, normalized to the total read number and shown
as transcripts per million reads (TPM, see methods)
[24]. To minimize the false positive signal, only reads
that were detected in both two sequencings (technical
replicates) were used for further bioinformatics analysis.
This small RNA quantification based on deep-sequencing
was highly reproducible, as reflected by a high Pearson’s
correlation coefficient between miRNA levels of the two in-
dependent P0 tissue samples (r =0.91) (Figure 1B). Consist-
ent with a peak of the length distribution at around 20–22
nt, we found that miRNAs were the major fraction of small
RNAs detected in rat cortex at all developmental stages


































































Size frac ona on
(~ 10 – ~ 35 nt)









Figure 1 Overview of deep-sequence results. A. Flow chart of the study. Briefly, RNAs were extracted from rat cortical tissues of different
developmental stages, size selected, and then sequenced by using the Solexa 1 G genome analyzer. Clean read tags were annotated by different
bioinformatics softwares (see methods). B. The comparison of read numbers per miRNA between the two P0 samples. Since the read number per
miRNA ranges from 0 to >10,000, the read number adding 1 was transformed by log10. Each dot represents data from one miRNA. There is a
high correlation between the two sequencing results (r= 0.91, Pearson’s correlation; p < 0.001(two tail). C-D. Relative abundances of different
classes of small RNAs. The chart (C) show the relative levels of each of the nine classes of small RNAs at different developmental stages. There
were <3% reads coming from the degradation of mRNAs (exon and intron). The heat-map (D) shows the developmental tendency of the total
amount of each class of small RNAs. Red and green indicate high and low expression, respectively.
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roles in the protein synthesis machinery. Interestingly, small
RNAs derived from rRNA at E13 were significantly higher
than all other stages (Figure 1C-D). Consistently, as shown
in Figure 1D, the total expression levels for small RNAs
derived from scRNAs, snRNAs, and snoRNAs, three
groups of small RNAs that contribute to the biogenesis of
rRNAs or to the protein synthesis, all significantly corre-
lated with that of rRNA-derived small RNAs, with a peak at
E13. Since E13 is characterized by onset of neurogenesis in
rat cerebral cortex [25], the peak of rRNA-derived smallRNAs at E13 suggests an important role of regulation of
protein synthesis for the onset of cortical neurogenesis.
Other classes of small RNAs detected in cortical tissues, in-
cluding piRNA-like RNAs and rasiRNAs as well as those
derived from tRNAs and srpRNAs, exhibited gradual re-
duction in their expression during development.
Identifying and profiling of known miRNAs
By aligning clean reads to precursors of known miRNAs
in the miRBase (release 18.0) [26], we identified approxi-
mately 280 known miRNAs and 55 miRNA* (miRNAs
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eight developmental stages (Table 1). Currently, there are
438 mature rno-miRNAs and 242 rno-miRNAs* deposited
in miRBase database, and close to fifty percent of these
known miRNAs are expressed in rat cortex. To further
validate the deep-sequencing results, we chose 21 miRNAs
with typical expression profile during development
(gradual increasing, gradual decreasing, and peak around
P0) for further analysis using the quantitative polymerase
chain reaction (qPCR) [27]. We found that the expression
patterns of most of these miRNAs revealed by qPCR were
consistent with deep-sequencing results (Figure 2) with
the exception of only four miRNAs (rno-miR-296, rno-
miR-93, rno-miR-99b and rno-miR-130a), which exhibited
minor discrepancy between qPCR and deep-sequencing
results at P0. These results further showed the high accur-
acy of deep-sequencing in detection and quantification of
the relative expression levels of most miRNAs. The
expression level of one extensively studied miRNA rno-
miR-134, which plays important roles in regulation of
embryonic stem cell differentiation and synapse plasticity
[28–30], was used as a relative standard to judge the
abundance of detected miRNAs. The expression levels of
rno-miR-134 in our samples were 350.10 and 326.51 TPM
at E13 and P14, respectively, and were less than 300 TPM
at other stages. We found that there were 50 miRNAs
whose expression was >300 TPM at more than one devel-
opmental stages, and 162 miRNAs exhibited <300 TPM
expression in all developmental stages. This means that al-
though most known miRNAs were detected in cortex,
only one-third was abundantly expressed and may play
significant roles during cortical development, although
other relatively low-abundance miRNAs may also play
some roles. The top 20 most abundant miRNAs at each
developmental stage are summarized in Table 2.
We observed that although there was no obvious dif-
ference in the total number of unique miRNAs detected
in cortex across different developmental stages, the ex-
pression level of different miRNAs in cortex was very












E10 278 56 110 51 40
E13 272 53 99 49 30
E17 263 54 74 36 27
P0 258 54 76 41 24
P3 263 54 72 37 24
P7 264 54 79 50 11
P14 267 54 85 55 12
P28 265 54 88 53 18analysis for all detected known miRNAs and 44 novel
miRNA candidates (see below) based on their relative
expression levels (Figure 2G). Dataset S1 shows a list of
these known and novel miRNAs in the order of cluster-
ing result. As shown in Figure 2, more miRNAs exhib-
ited higher expression level in earlier developmental
stages than later stages. Nearly 40 % of miRNAs had the
highest abundance at E10. Moreover, more miRNAs
exhibited a higher abundance in early developmental
stages (E10 and E13) and late developmental stages
(P7-P14) than in middle stages (E17-P3). Overall, the ex-
pression patterns of miRNAs fell into four main categor-
ies: (1) Enriched in early embryonic stages, especially at
E10 and E13 and decreased gradually during develop-
ment (i.e. the rno-miR-181 family); (2) Enriched late
postnatally, especially at P14 and P28, and tended to in-
crease over time (i.e. rno-miR-29a and rno-miR-128);
(3, 4) Peaked around neonatal stage (P0), either highest
peak or lowest peak.
The expression profile of miRNAs provides a hint of
their potential functions during development. For ex-
ample, at E10, which is a stage of fast proliferation and
expansion of cortical progenitor cells, more than 100
miRNAs exhibited higher expression than any other
developmental stages. Some of these miRNAs, i.e. rno-
miR-34c, rno-miR-449a, rno-miR-301b, rno-miR-532-5p,
rno-miR-219-5p, rno-miR-451, and rno-miR-152, were
even 10-fold more abundant at E10 than at any other
stages, providing a hint that these 7 miRNAs may play
important roles in the regulation of progenitor cell pro-
liferation. At about E13, when the first waves of neurons
are produced from neural progenitor cells in rat cortex
[25], we found that 4 miRNAs were particularly high at
this stage, including rno-miR-199a-3p, rno-miR-494,
rno-miR-182, and rno-miR-7a, suggesting important
roles of these miRNAs in neurogenesis. At neonatal
stage (around P0), when the majority of pyramid neu-
rons have already migrated to their destinations and are
extending axons and dendrites [31], we found high
expression of several miRNAs at this stage, i.e. rno-miR-
137 and rno-miR-19b. Consistently, a previous study
showed that miR-137 regulates neuronal maturation by
targeting the ubiquitin ligase Mib-1 [32]. Dataset S1 pro-
vides a complete list of the name and relative abundance
(TPM) of all detected known miRNAs.
We note that during the preparation of this manuscript,
one group reported the identification of two novel miRNAs
from the brain tissue named as rno-miR-344b-5p and rno-
miR-3559-5p [33]. Our work further verified their finding
of these two novel miRNAs in brain tissues (Figure S3).
The expression of rno-miR-344b-5p gradually elevated dur-
ing development, suggesting that its function may involve
late developmental processes like the synapse development
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Figure 2 (See legend on next page.)
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Figure 2 Validation and clustering analysis of developmentally regulated miRNAs. A-C. The expression of three groups of miRNAs at
different developmental stages revealed by deep-sequencing. The three groups are: gradual increasing (A), gradual decreasing (B), and peak at
middle stages (C). The expression level of miRNAs (TPM) at each developmental stage was normalized to that at E10. D-F. Quantitative PCR
(qPCR) analysis of the expression profile of different groups of miRNAs shown in A-C. Results are based on average of three independent
experiments (Mean± SD). The developmental changes of the expression of most miRNAs revealed by qPCR are consistent with results from deep-
sequencing. G. Clustering of differentially expressed microRNAs. The Complete Linkage Clustering was used by R package based on expression
levels (TPM) of each miRNA at different stages. Both known miRNAs and novel miRNAs are included (Dataset S1). Red means highly expressed
and green means lowly expressed.
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tial role in embryonic neurogenesis.
Identification of potential novel miRNAs in cortex
One advantage of deep-sequencing in miRNA detection
is its ability to discover potential novel miRNAs. In the
current study, the miReap algorithm [35] (Http://source-
forge.net/projects/mireap) was employed to call all
candidate miRNA precursors with hairpin-like structures
(see methods). Altogether, 101 potential novel miRNAs
were identified in this study when annotated to the miR-
Base release 18.0. Dataset S2 provides a complete list of
the name and relative abundance for all novel miRNA
candidates based on annotation to release 18.0 of miR-
Base. The predicted structure of 11 newly identified
miRNAs are shown in Figure S4 as examples. The exist-
ence of these 11 novel candidates was further verified by
RT-PCR, together with several recently identified miRNAsTable 2 The top 20 highly expressed miRNAs at different dev
E10 E13 E17 P0
rno-let-7c rno-let-7c rno-let-7c rno-let-7c
rno-miR-9 rno-let-7a rno-let-7a rno-miR-124
rno-let-7a rno-miR-199a-3p rno-let-7f rno-let-7a
rno-miR-103 rno-miR-103 rno-miR-99a rno-let-7f
rno-let-7f rno-let-7e rno-let-7d rno-miR-128
rno-miR-199a-3p rno-miR-99a rno-let-7b rno-let-7b
rno-miR-107 rno-let-7f rno-miR-9 rno-miR-99a
rno-miR-181a rno-miR-140* rno-miR-124 rno-miR-9
rno-miR-101b rno-miR-107 rno-miR-128 rno-miR-103
rno-let-7e rno-miR-9 rno-miR-103 rno-let-7d
rno-miR-124 rno-miR-30d rno-let-7e rno-miR-101a
rno-miR-140* rno-miR-124 rno-miR-125b-5p rno-miR-107
rno-miR-101a rno-let-7d rno-miR-107 rno-let-7e
rno-miR-181b rno-miR-30a rno-let-7i rno-miR-125b-5p
rno-miR-30a rno-miR-7a rno-miR-101a rno-let-7i
rno-miR-181d rno-miR-320 rno-miR-30d rno-miR-181a
rno-let-7i rno-miR-191 rno-miR-30a rno-miR-101b
rno-miR-320 rno-miR-101a rno-miR-9* rno-miR-140*
rno-miR-99b rno-miR-101b rno-miR-191 rno-miR-320(rno-miR-2964, rno-miR-344b-5P, and rno-miR-3559-5p).
We found that those with extremely low reads failed
to be consistently detected using PCR (Figure 3A).
Overall, eight of the 11 novel candidates were verified
by PCR (Figure S5). The expression pattern of 2 highly
expressed novel candidates were also verified using
qPCR with consistent results as that of deep-
sequencing (Figure 3B-D). The number of potential
novel miRNAs detected by deep-sequencing was very
diverse over development (Table. 1), and the expres-
sion level of most novel candidates was very low. Out
of the total 101 novel candidates, only 2 candidates
were expressed at a relatively high abundance and
were thus more likely to play important biological
functions in brain. Among these 2 candidates, Candi-
date 55 was enriched at E10 (259.55 TPM), and was
not detected in any other developmental stages. The
expression level of the Candidate 11 reached a peak atelopmental stages
P3 P7 P14 P28
rno-let-7c rno-let-7c rno-miR-128 rno-miR-128
rno-miR-128 rno-miR-128 rno-let-7c rno-let-7c
rno-let-7f rno-let-7f rno-let-7f rno-let-7a
rno-let-7a rno-let-7a rno-let-7a rno-let-7f
rno-let-7b rno-let-7b rno-let-7d rno-let-7d
rno-miR-124 rno-miR-124 rno-let-7b rno-miR-29a
rno-miR-103 rno-let-7d rno-miR-124 rno-let-7b
rno-miR-9 rno-miR-99a rno-miR-99a rno-miR-124
rno-miR-107 rno-miR-103 rno-miR-103 rno-miR-103
rno-let-7d rno-let-7i rno-miR-107 rno-let-7e
rno-miR-101a rno-miR-107 rno-let-7e rno-miR-107
rno-let-7i rno-miR-30d rno-miR-30d rno-miR-99a
rno-miR-101b rno-miR-9 rno-let-7i rno-let-7i
rno-miR-181a rno-miR-101a rno-miR-9 rno-miR-30d
rno-miR-125b-5p rno-miR-30a rno-miR-29a rno-miR-9
rno-let-7e rno-miR-9* rno-miR-30a rno-miR-30a
rno-miR-320 rno-let-7e rno-miR-101a rno-miR-101a
rno-miR-140* rno-miR-101b rno-miR-185 rno-miR-219-2-3p
rno-miR-99a rno-miR-185 rno-miR-101b rno-miR-185
BA
C





































Counts RT-PCR Counts RT-PCR
E17 P0 P7
Counts RT-PCR
Candidate 1 TGGCTATGATGTTTACTACCT 8 + 16 + 0 +
Candidate 2 TAAGTGTGTATGTATATGTG 25 + 26 + 19 +
Candidate 3 ATGTAAGTGTGTATGTATAT 19 - 24 - 14 -
Candidate 4 GGACGTCCAGACGCAACT 110 + 54 + 43 +
Candidate 5 TGTGATGTGTGTATGTATAT 26 + 13 + 15 +
















10 TAAGCTTGCCTTAGGATTGTTG 0 67
















































































































Figure 3 Validation of the expression of novel miRNAs. A. Summary of the RT-PCR analysis of the 11 selected novel miRNAs. Novel
candidates with extremely lower abundance can be detected by deep-sequencing but not by PCR amplification. Counts mean the numbers of
each unique read coming from deep sequencing. B. Validation of the expression profile of 2 highly expressed novel miRNA candidates
(candidate 11, candidate 55) by qPCR. All experiments were repeated for 3 times. Error bars represent standard deviation. The relative expression
was normalized to E10 value for both qPCR and TPM. There is a high correlation between the deep-sequencing and qPCR results. C. Expression
of the candidate in different tissues. The relative expression of miRNAs in different tissues was normalized to that of cortex. Note that all of them
are enriched in the central nerve system. Experiments were repeated for 4 times. Error bars represent standard error deviation (n = 4; *P < 0.05). D.
Regulation of C6 cell proliferation by Candidate 11. Overexpression of Candidate 11 promoted cell proliferation, whereas suppressing the
endogenous Candidate 11 by overexpression of a sponge RNA (6X) reduced cell proliferation. Experiments were repeated for 3 times. Error bars
represent standard error of the mean (n = 3; *P < 0.05).
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rat cerebral cortex [36]. Next, we compared the expression
level of Candidate 11 in different tissues including cortex,
hippocampus, cerebellum, skin, heart, and skin. We found
that this novel candidate was enriched in central nerve
system (Figure 3C).
To test whether the biogenesis of novel candidates
depends on Dicer, we compared the expression level of
mouse homologues of candidate novel miRNAs in cortical
tissue of wild type mice and mutant littermates of brain-
specific knockout of Dicer (Nestin-Cre, Dicer-floxed). As
positive control, the expression of three known miRNAs,
miR-134, miR-124, and the newly identified miR-344b-5p,
was significantly reduced in Dicer knockout brain. The ex-
pression levels of mouse Candidate 11 also significantly
decreased in homozygous knockout brains (Figure S6),
further supports the notion that it indeed belongs to the
category of miRNA.
Dataset S2 provides a complete list of the name and
relative abundance (TPM) for all detected novel miRNAs,
some of which were selected for clustering analysis to-
gether with known miRNAs (Figure 2G; Dataset S1). To
get functional hints for these novel candidates, we pre-
dicted the potential target genes of these miRNAs by using
TargetScan [37], and carried out gene ontology (GO) en-
richment analysis with GOrilla of predicted target genes
(Dataset S3). We found that the potential function of Can-
didate 11 may be involved in regulating energy production
and G-protein-coupled receptor signaling pathway. Con-
sidering that Candidate 11 has highest expression at P3,
which is a peak stage for gliogenesis in cortex [36], we fur-
ther examined whether it affects the proliferation of glial
cells using cultured rat C6 glial cell line. Interestingly,
overexpression of Candidate 11 in C6 cells increased the
cell proliferation, whereas suppressing the endogenous
Candidate 11 by overexpressing a specific sponge RNA
[38] reduced the cell proliferation (Figure 3D). This result
supports the notion that this novel miRNA may regulate
the gliogenesis during cortical development.
Potential stage-specific RNA modification during cortical
development
Recent studies showed that miRNAs may undergo cleav-
age at the 3’ end by specific exoribonuclease, resulting in
the existence of multiple isoforms of variant lengths
(isomiRs) [39]. We note that in all cortical RNA samples,
variability in the length of miRNAs was detected as
addition and/or trimming of nucleotides at both 3’ end
and 5’ end of mature miRNAs. Majority of known miR-
NAs underwent trimming at both 3’ and 5’ ends. However,
trimming for several miRNAs including rno-miR-1*, rno-
miR-196a*, rno-miR-207, rno-miR-347, and rno-miR-742
was not detected, possibly due to the low abundance of
trimmed isoforms rather than a selective protection ofmodifications. Consistent with previous findings in Drosoph-
ila [40] and in Human[41], we found that 3’ end trimming is
the most frequent type of isomiR in all cortical samples
(Figure S7). This also suggests that there is no stage-
specific regulation of the trimming of miRNAs. Dataset S4
provides a complete list of the name and relative abun-
dance (TPM) of all detected isomiRs of known miRNAs.
RNA editing has emerged as one important posttran-
scriptional mechanism that introduces nucleotide changes
in RNA sequence, such as cytidine (C) to uridine (U) and
adenosine (A) to inosine (I) via deamination [42], and may
play important regulatory roles in the nervous system
[43]. Although the majority of editing events happens to
pri-miRNA and appear to affect the miRNA processing
step, some nucleotide alterations happen in the “seed”
sequence of mature miRNAs [44]. These edited mature
miRNAs with altered “seed” sequence are likely to sup-
press a set of genes different from those targeted by un-
edited miRNAs. We systemically examined the nucleotide
changes of mature miRNAs by alignment of unannotated
tags with mature sequence of miRNAs allowing one
nucleotide mismatch [45, 46]. We discovered 160 miRNAs
with single nucleotide modification located across the
mature sequence with obviously higher frequency of
modification detected at the “seed” and flanking regions
(Figure 4A). The existence of such a peak in nucleotide
changes at “seed” and flanking sequences suggests that
most observed nucleotide changes were not caused by
random mutations during sequencing, but by active
miRNA editing in the cell. Besides the well-known “A” to
“I” modification, many other RNA editing events were also
discovered such as “A” to “C” and “G” to “T” (Dataset S5),
consistent with a widespread RNA editing discovered in
previous human transcriptome studies [47–49]. Although
the expression level of the majority of edited miRNAs was
very low, some particularly high frequent editing events
happened at certain developmental stages. Taking rno-
miR-128 as an example, highest frequency of “A” to “C”
editing at position 3 and “G” to “T” editing at position 6
was observed at P14, whereas “G” to “T” editing at pos-
ition 8 was highest at P3 (Figure S8).
We found that the number of miRNAs with a relatively
high editing events (>50 TPM) was much higher after P7
than at earlier developmental stages (Figure 4B). Moreover,
the percentage of total edited miRNA reads among total
miRNA reads was also much higher after P7 than earlier
stages (Figure 4C). Similar tendency was observed for miR-
NAs of high editing events (>50 TPM) (Figure 4D). These
results suggest the necessity of miRNA editing for complex
regulation of gene expression at late postnatal stages,
potentially contributing to the complicated synaptic wiring.
As a distinguished representative of miRNA editing, rno-
miRNA-376 family have been extensively studied [5]. The
























































































































































































regulation of synaptic transmission
localization of cell regulation of membrane potential
synapse maturation
potassium ion homeostasis
axon midline choice point recognition
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Figure 4 Characterization of miRNA editing during cortical development. A. Cumulative counts (TPM) of editing at each position of all
mature miRNA sequences at different developmental stages. The editing events were enriched at “seed” sequence (position 2 to 8) and flanking
region (position 12 to 15) of miRNAs. B. Summary of miRNA editing at different stages detected by deep-sequencing. There are more edited
miRNAs and modified positions at P28 than other stages. The number of highly edited miRNAs (TPM> 50) gradually elevated during
development. C-D: The percentage of total edited miRNA reads among total miRNA reads was much higher after P7 than earlier stages (C).
Similar tendency was also observed for miRNAs of high editing events (>50 TPM) (D). E. Developmental changes of the expression of wild type
(WT) and “A” to “I” edited miRNA-376b at position 6 (A/G: 6). The level of edited form exceeded that of WT from P7. F. Summary of biological
processes that may be regulated by WT and edited (A/G:6) miRNA-376b. All target genes of the wild type and edited miRNAs were predicted by
TargetScan and statistically over-represented GO annotations were included (P< 0.01). Note that GO terms of WT are those involved in early
development of cortex. Those GO terms unique to edited miRNA targets are associated with establishment and maintenance of neural circuitry.
G. Validation of “A” to “I” editing of miRNA-376b at position 6. RNAs from P7 rat cortex were reverse transcribed and then amplified by PCR. The
PCR product was sequenced. A heterozygous change A-G was detected at position 6 (arrow).
Yao et al. BMC Genomics 2012, 13:232 Page 10 of 16
http://www.biomedcentral.com/1471-2164/13/232of rno-miRNA-376b was also detected in the present study
by both deep-sequencing and PCR-based sequencing
(Figure 4G). Deep-sequencing results showed that the level
of this “A” to “I” editing at position 6 of rno-miRNA-376b
increased during cortical development. Surprisingly, the ex-
pression level of edited sequence exceeded that of the wild
type form from P7 and reaches the peak at P28 (Figure 4E),
indicating that the edited sequence may play important
roles in late postnatal development of cortex. To further
understand the biological significance of this editing event
of rno-miR-376b, target prediction and GO analysis was
introduced (Dataset S6). We found that the potential func-
tion of wild type rno-miR-376b may be mainly related to
early developmental events including neuronal differenti-
ation, cell migration, axon extension, and establishment or
maintenance of neuronal polarity. However, the potential
function of the edited isoform shifted to the regulation
of late developmental events including synaptic plasticity,
learning and memory, and adult feeding behavior
(Figure 4F, Dataset S6). Interestingly, results of this GO
analysis are fully consistent with the high expression of the
wild type rno-miR-376b and the edited isoform at early de-
velopmental stages and late postnatal stages, respectively.
Dataset S5 provides a complete list of the name and relative
abundance (TPM) for all detected editing of miRNAs, with
TPM >100 highlighted.
Discussion
Accumulating evidences showed that different groups of
small non-coding RNAs play fundamental roles in gene
regulatory networks. As the most abundant group of
small RNAs in many tissues, miRNAs play important
regulatory roles in physiological and developmental pro-
cesses. In the nervous system, miRNAs can also function
as important mediator of various pathological processes
[50]. Recently, exogenous expression of miR-9/9* and
miR-124 in human fibroblasts was shown to convert
these cells into neurons [51, 52], suggesting the wide ap-
plication potential of miRNAs. Here, we took advantage
of high-throughput sequencing technology to quantita-
tively analyze the expression of miRNAs in rat corticaltissues of many developmental stages. We found that
miRNAs showed a wide diversity of expression pattern
during cortical development. Some miRNAs seem to be
preferentially enriched in early embryonic cortex, whereas
others exhibited a higher abundance in postnatal tissue,
indicating distinct roles played by these different groups of
miRNAs in controlling cortical development. The expres-
sion patterns of some miRNAs observed in our study are
consistent with what were observed in previous studies by
using the blot-array and Northern blot assays, i.e. miR-
125b, miR-9, and miR-181a [6], as well as miR-29a, miR-
138 and miR-92 [53]. We note that the developmental
expression pattern of miRNAs provides a hint of their
potential functions. The dataset described here will thus
provide an enriched resource for searching miRNAs that
may play key regulatory roles at different stages of cortical
development. In support of this notion, we observed that
the novel miRNA Candidate 11 promoted the prolifera-
tion of cultured C6 glial cells, consistent with the high
expression of this miRNA around the peak stage for glio-
genesis in cortex (P3). It would also be very interesting to
explore whether the expression of this novel miRNA cor-
relates with and contributes to the happening of glioma in
human patients.
One recent study reported strain-specific miRNAs in
rats. The authors provided an in-depth analysis of small
RNA profiles of six different tissues (spleen, liver, brain,
testis, heart, kidney) of two different rat strains (BN-Lx
and SHR) [33]. We found that the majority of miRNAs
they discovered can be confirmed in our study. Several
miRNAs including rno-miR-582, rno-miR-666-3p, and
rno-miR-2985-3p were not detected in our study. In
contrast, several E10-enriched miRNAs identified in our
study, including rno-miR-181a, rno-miR-449a, and rno-
miR-503, were not detected in their results. These differ-
ences in miRNA detection may due to the failure of
detection of some low abundance ones in different stud-
ies. The existence of strain-specific expression of several
miRNAs may also be responsible for the differential de-
tection in different studies. Moreover, we detected the
expression of low abundance miRNAs that have not
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ample is miR-128, which was reported to be specifically
expressed in postnatal cortex [6]. However, our results
showed that miR-128 was also expressed in embryonic
cortex with much lower abundance, indicating that high
throughput sequencing is much more sensitive than
conventional methods.
Besides the identification of dozens of novel miRNAs at
each developmental stage, we observed in developing cor-
tex extensive RNA editing in the miRNA “seed” and flank-
ing sequences. Since most nucleotide changes at specific
position of miRNAs was detected up to hundreds or even
thousands of times, and the relative abundance of certain
modified miRNAs at different developmental stages was
not proportional to that of the wild type miRNAs, it is un-
likely that the nucleotide changes we observed were
caused by random errors during sequencing. The high
tendency of nucleotide changes at “seed” and flanking se-
quence also supports the existence of a highly-regulated
“editing” process (Figure 4B). We found that the predicted
target genes of the wild type rno-miR-376 and the “A” to
“I” edited isoform are of totally different functional groups
(Figure 4F). Interestingly, the relative abundance of “A” to
“I” editing of rno-miR-376 gradually increased during de-
velopment and surpassed that of wild type isoform at P7,
indicating that RNA editing may be a new strategy for the
regulation of gene expression during brain development.
Previous study showed that adenosine deaminases
(ADARs) catalyze the “A” to “I” editing of RNAs [54].
Editing of glutamate receptor by ADARs is involved in
neural development and diseases [55, 56]. Cytidine de-
amination by members of the apolipoprotein B mRNA
editing complex polypeptide 1-like (APOBEC) family of
enzymes has also been shown to be an important
mechanism for the silencing of retrovirus and transpos-
able elements [57]. Interestingly, our preliminary study
showed that both ADAR and APOBEC family members
could be detected in developing cortical tissue (data not
shown). For the miRNA editing in developing cortex, a
number of questions remain to be clarified in the future:
(1) Are ADAR and/or APOBEC family proteins respon-
sible for the different types of editing of cortical miR-
NAs? (2) Are there other enzymes contributing to the
miRNA editing in cortex? (3) How the nucleotide-
specificity of the editing is achieved? (4) How is the
miRNA editing regulated by intracellular signal cascades
during development? Extensive experimental studies are
required in the future to address these questions.
Previous studies showed that rasiRNAs and piRNAs are
of the same origin, yet with slight differences in the way of
identification and nomenclature. [58]. The rasiRNAs were
first defined as small RNAs derived from repeat elements,
mainly transposons, in the genome [59, 60]. However,
piRNAs were first identified as small RNAs associatedwith PIWI proteins in germline tissues [61]. Later studies
showed that both rasiRNAs and piRNAs are derived from
repeat elements [62] and serve to suppress the activity of
transposable elements by guiding the epigenetic silencing
of the transcription of transposable elements and by guid-
ing the direct cleavage of transcripts of these transposons
[63]. Recently piRNAs were detected in adult cerebral cor-
tex of rat and showed altered expression after transient
focal ischemia [64]. Nearest, piRNAs were reported as
functional regulator of enhancing long-term synaptic fa-
cilitation through silencing CREB2 [65]. Here we detected
a low-abundance expression of a group of piRNA-like
small RNAs in developing cortex of rat based on the
sequence mapping to reference libraries (piRNA Bank,
http://pirnabank.ibab.ac.in/index.shtml) [66]. Moreover,
we observed in cortical tissues the expression of PIWI-like
proteins (data not shown), which play important roles in
the biogenesis and function of piRNAs or rasiRNAs [58],
further supporting the existence of piRNAs or rasiRNAs
in brain. Interestingly, recent studies showed that retro-
transposable events actively happen during neurogenesis
and may contribute to the diversity of neuronal pheno-
types [67, 68]. Since we observed much higher rasiRNA
level at early developmental stages than in the adult, an in-
triguing possibility is that rasiRNAs in developing cortex
may also contribute to the maintenance of the genome
stability in neural progenitor cells by suppressing the mo-
bile elements, a potential mechanism that deserves to be
further addressed by experimental studies in the future.
Conclusion
High-throughput sequencing provides a good opportunity
to systematically analyze the transcriptome of small RNAs
of cortical tissues. In this study the use of this technique
led to the quantitative clarification of the expression of a
large number of previously un-detected small RNAs in
cortical tissues, including miRNAs, rasiRNAs and/or
piRNA-like RNAs, and small RNAs derived from rRNA,
tRNA, snoRNA, snRNA, and scRNA. We demonstrated
dynamic and stage-specific expression of a large group of
known miRNAs, with surprisingly profound nucleotide
editing at “seed” and flanking sequences of miRNAs
during cortical development. In addition, we identified a
group of novel miRNA candidates in rat cortex with func-
tional hints. The dataset described here will be a valuable
resource for clarifying the gene regulatory network during
brain development and disease.
Methods
Animals
All rats and mice used in the present study were pro-
vided by Shanghai SLAC Laboratory Animal Co. Ltd.
Experimental procedures involving animals were carried
out under the guideline and permission of the Animal
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ence at the Shanghai Institute for Biological Sciences,
Chinese Academy of Sciences (NA-100410-4).
RNA extraction, construction of small RNA libraries, and
deep-sequencing
Rat (Sprague–Dawley) cortical tissues of various develop-
mental stages were quickly harvested on ice. For E10 and
E13 brains, the whole cortex tissues were collected. For
E17-P28 brains, the dorsal lateral regions of the cortex,
mainly the somatosensory cortex, were collected. Subcor-
tical tissues and meninges were carefully removed under
dissecting microscope. For collection of cortical tissues of
wild type and Dicer knockout mice, Dicer-floxed mice were
crossed with the Nestin-Cre line to knockout Dicer in
brain. E16 cortical tissues of wild type and homozygous
mutant embryos were dissected under microscope. Total
RNA was then extracted with TRIzol reagent (Invitrogen,
Carlsbad California) following the manufacturer’s instruc-
tion. The RNA integrity number (RIN), an algorithm for
judging the integrity of RNA samples, were evaluated using
Agilent 2100 Bioanalyzer (Agilent Technologies, Paloalto,
USA) following the manufacturing instruction. Size-
fractionation was performed on 15% polyacrylamide gel
electrophoresis (PAGE) to collect the 10–35 nt fraction.
Small RNA library construction and deep sequencing
were carried out by BGI (Beijing Genome Institute at
Shenzhen, China). Briefly, adapters were ligated to the 5’
and 3’ termini of these small RNAs, which then were
used as templates for cDNA synthesis. After producing
libraries via PCR amplification, purified PCR products
were then sequenced using the Solexa 1 G Genome
Analyzer to get 35 nt reads. After filtering out low qual-
ity reads, trimming the adapter sequence, cleaning up
contaminants formed by ligation, clean reads of 18–30
nt were grouped and used for further analysis.
Computational analyses
Clean reads of unique small RNA tags were counted as
their expression abundances. Those identical RNA tags
were mapped to rat genome (Baylor 3.4/rn4) by SOAP
software (Short Oligonucleotide Alignment Program,
http://soap.genomics.org.cn) to analyze the expression of
corresponding small RNA genes and their distribution
on the genome. Small RNA tags were aligned to the
miRNA precursor and mature sequences from miRbase
18.0 (www.miRBase.org) to obtain the known miRNA
counts. Unannotated tags were aligned to the sequences
of other class of non-coding RNAs (rRNA, tRNA,
scRNA, snRNA, snoRNA and piRNA) from Rfam [69,
70] (http://www.sanger.ac.uk/software/Rfam) and the
GenBank (http://www.ncbi.nlm.nih.gov/). The read count
of each unique tag was normalized to transcripts per
million (TPM), according to the total read count.To identify potential novel miRNAs, the software Mir-
eap (http://sourceforge.net/projects/mireap) was used to
explore the secondary structure, the Dicer cleavage site,
and the minimum free energy of the unannotated small
RNA tags which could be mapped to genome. In brief,
the sequence length should be between 18–26 nt, max-
imal free energy allowed for a miRNA precursor was
~18 kcal/mol, maximal space between miRNA and
miRNA* was 35 nt, and flanking sequence length of
miRNA precursor should be 10 nt. After filtering in
above analysis pipeline, unannotated small RNA tags
were aligned with mature miRNAs from miRBase18.0 to
detect miRNA editing allowing one mismatch on certain
position of miRNAs. To eliminate sequence changes
generated by single-nucleotide polymorphism (SNP) at
the genomic DNA, the results were filtered with SNP
database (Build 130) (http://www.ncbi.nlm.nih.gov/pro-
jects/SNP/index.html). IsomiR analysis was conducted
by aligning the reads to precursor sequence and mature
sequence of miRNAs. IsomiRs were divided into 8
groups as follows: 1, Addition of nucleotides at both 3’
and 5’ ends; 2, Addition of nucleotides at 5’ end; 3,
Addition of nucleotides at 3’ end; 4, Addition at 5’ end
and trimming of nucleotides at 3’ end; 5, Trimming at 5’
end; 6, Trimming at both 3’ and 5’ ends; 7, Trimming at
3’ end; 8, Trimming at 5’ end and addition at 3’ end.
Pearson’s correlation algorithms were used to assess the
correlation between read counts per miRNA of the two
P0 samples.
Clustering analysis and heat map presentation
Heat map about relative abundances of different classes of
small RNAs was done as follows. All abundance values are
normalized by the E10 value and colored in terms of sig-
nificance, with green indicating that abundance of a term
is significantly lower than average, and red indicating
higher than average [71]. Over-representation for each
term in a group is calculated as follows:
Computation 0:5emformula : Z ¼ X Avgð Þ=SD:
Where X is the abundance of a term in the group
being considered, Avg is the average abundance of a
term in all developmental stages, and Z presents the
relative abundance of a term at a given developmental
stage. The Complete Linkage Clustering of known and
novel miRNAs was obtained based on Hierarchical Clus-
tering Algorithms by using the R package [72].
Target prediction and gene ontology analysis
The potential target genes were predicted by Tar-
getScan [37] and then assayed by Gorilla [73] with
gene ontology (GO) enrichment analysis (http://cbl-
gorilla.cs.technion.ac.il/).
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Reverse transcription reactions were performed in a final
volume of 20 μl containing 2 μg purified total RNA, 1×RT
buffer (Promega, USA), 10 mM dNTPs, 5 U M-MuLV re-
verse transcriptase (Promega, USA), 20 U RNase inhibitor
(Fermantas, USA) and 0.4 μM stem-loop RT-primers. The
reactions were incubated in Thermo Cycler (BioRad, USA)
at 37°C for 60 min, 90°C for 5 min and then held in 4°C.
Realtime PCR was performed on 7500 Fast Real-time
PCR system (Applied Biosystems,USA)(27). In brief, reac-
tions were performed in a final volume of 20 μl containing
10 μl SYBR W Green Master mix, 1 μl RT products
(diluted for 10 times), 1 μM unique primer of certain
miRNA, and 1 μM out-primer match to the stem-loop
sequence. PCR reaction was carried out with a first de-
naturation step at 95°C for 20 sec, followed by 45 cycles
comprising denaturation at 95°C for 12 sec, annealing and
extension at 56°C for 30 sec. Melting curve was run in
program following 95°C, 15 sec; 60°C, 20 sec; 95°C, 15 sec;
60°C, 15 sec. To normalize the differences of the amount
for different samples, U6 was used as internal control as
well as experimental positive control. Negative controls
(without template) were also established and all experi-
ments were run in triplicate. The 2T
-ΔΔC method was ap-
plied for relative expression quantification analysis [74]
and E10 value was used as reference. All PCR products
were cloned into pGEM-T vector (Promega, USA) and
then sequenced. Primers used are shown in Dataset S7.
PCR analysis
For PCR verification of novel miRNAs, reverse transcrip-
tion was performed with Revert Aid First Strand cDNA
Synthesis kit (MBI Fermentas) using specific stem-loop
primer (Dataset S7). PCR was carried out with a first de-
naturation step at 95°C for 3 min, followed by 35 cycles
comprising denaturation at 95°C for 20 sec, annealing at
60°C for 25 sec, and extension at 72°C for 45 sec. PCR
products were separated by agarose electrophoresis.
For PCR analysis of Piwi expression, synthesis of first
strand cDNA was carried out with a Revert Aid First
Strand cDNA Synthesis kit (MBI Fermentas). PCR was
carried out using cDNA with the following protocols:
Initiate denaturation at 94°C for 5 min; denaturation at
94°C for 45 sec, annealing at 62°C for 30 sec, extension
at 72°C for 45 sec, and a 10 min 72°C final extension.
Cycle numbers for actin, Piwil1, 2, and 4 were 25, 35, 42,
and 42. Predicted sizes for PCR products for Piwil1, 2,
and 4 are 178 bp, 152 bp, and 179 bp, respectively. Pri-
mers used are shown in Dataset S7.
For PCR verification of editing of miR-376b, genomic
DNA and cDNA from P7 rat cortex were used as template.
PCR was performed as following protocols: Initiate de-
naturation at 94°C for 5 min; denaturation at 94°C for
45 sec, annealing at 60°C for 30 sec, extension at 72°C for45 sec, PCR program was run for 35 cycles, with a 10 min
72°C final extension. PCR products were treated with SAP
(1U) and Exonuclease I (20U) (Takara, Japan) and then sub-
jected to direct DNA sequencing in both directions using
forward and reverse primer with an ABI PRISM 3100-
Genetic Analyzer (Applied Biosystems). Sequenced PCR
products were aligned to precursor sequence of miR-376b
using the DNAstar program. Primers used are shown in
Dataset S7.
Plasmid construction and cell proliferation assay
The genome locus of novel Candidate 11 was amplified
using PCR and subcloned into ClaI/XhoI site of the
pCAG-IRES-EGFP vector. For construction of sponge in-
hibitor, the synthesized nucleotides with 6 tandem repeat
sequence complementary (6X) to mature sequence of
Candidate 11 was annealed and cloned into pEGFP-C1.
Cell proliferation assay was performed as described previ-
ously [75]. Briefly, C6 glial cells were prepared as cell sus-
pension of 50,000 cells/ml in DMEM with 10% fetal
bovine serum (Gibco) and transfected with different con-
structs (3 μg) using the Amaxa Nucleofector kit following
the protocol provided by the manufacturer. Each well of a
96-well plate was added with 100 μl of the cell suspension.
Culture plate was incubated for 44 hr at 37°C and then
added 10 μl CCK-8 solution (Dojindo, japan) into each
well, and incubated the plate for another 4 hr at 37°C fol-
lowed reading the OD at 450 nm to determine the cell
viability in each well.Additional files
Additional file 1: Figure S1. RNA integrity number (RIN) of all
samples. Electropherograms and calculated RINs of each RNA sample are
shown. 18 S and 28 S ribosomal fractions are indicated in pink and dark
green colors, respectively. Note that RIN values are between 8.4 and 10,
indicating high quality of RNA samples.
Additional file 2: Figure S2. Length distribution of small RNA reads.
The length distribution of small RNA reads for each sample is shown in
the histogram. Only reads of 18–30 nt that mapped to rat genomic
sequence were included. Note the 22 nt peak in all samples.
Additional file 3: Figure S3. Validation of the expression of miR-
344b-5p and miR-3559-5p. The expression of miR-344b-2 gradually
elevated during development. Expression of miR-3559-3p dropped over
development, with a peak at E13. These two miRNAs highly enriched in
central never system.
Additional file 4: Figure S4. Predicted structures of newly
identified miRNAs. Computationally predicted secondary structures of
the primary miRNA transcripts of 11 selected novel miRNA candidates are
shown. Mature miRNA sequences are shown in the red frame.
Additional file 5: Figure S5. PCR detection of novel miRNA
candidates. Three known miRNAs, miR-2964, miR-344b-5p, and miR-
3559-5p were also included as control.
Additional file 6: Figure S6. Detection of mouse homologue of
Candidate 11 in cortical tissue of mutant mouse with brain-specific
knockout of Dicer. A. Genotyping of mutant mice. Nestin-Cre allele
generated one band. Heterozygous Dicer-floxed allele generated two
bands and homozygous allele generated one upper band. B. Expression
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http://www.biomedcentral.com/1471-2164/13/232level of novel Candidate 11 in P0 cortical tissue of Dicer knockout
(Nestin-cre/Dicer-floxed+/+) mice revealed by qPCR. Expression level of
Candidate 11 significantly decreased in knockout mice. C. Expression level
of three known miRNAs, miR-344b-3p, miR-124, and miR-134, in P0
cortical tissue of wide type and Dicer knockout mice revealed by qPCR.
Expression level of the three known miRNAs was remarkably decreased in
knockout mice.
Additional file 7: Figure S7. Summary of potential isomiRs in
cortical tissues. A. Summary of the fraction of each major group of
isomiR in cortical tissue. Variability in the length of miRNAs was detected
as addition and/or trimming of nucleotides at either 3’ end or 5’ end of
mature miRNAs. Note that the 3’ end trimming is the most frequent type
of modification in all samples. B. A summary of the sequence, length, and
count of each isomiR of miR-128 in P14 cortical tissues.
Additional file 8: Figure S8. Detail editing profile of miR-128
during cortical development. A summary of the position, sequence,
abundance (TPM) of each detected editing of miR-128 is shown. The
high-abundance edited positions are highlighted with red color.
Additional file 9: Table S1. Summary of reads from the deep-
sequencing results.
Additional file 10: Dataset S1. List of the name and relative
abundance (TPM) for all known miRNAs and novel miRNAs. All
miRNAs are listed in the order of clustering result shown in Figure 2.
Additional file 11: Dataset S2. List of novel miRNA candidates. The
name and relative abundance (TPM) for all novel miRNA candidates are
shown. List of 44 selected novel miRNA candidates and precursor
sequences of 11 selected novel miRNA candidates are also included.
Additional file 12: Dataset S3. Predicted targets and GO
annotation of three novel candidates.
Additional file 13: Dataset S4. List of the name and relative
abundance for all detected isomiRs. The name and relative abundance
(TPM) of isomiRs for all known miRNAs in different samples are shown.
Additional file 14: Dataset S5. Summary of all detected editing of
miRNAs. List of the name, position, and relative abundance (TPM) for
detected editing of miRNAs at each developmental stage is shown. High
abundant editing is highlighted in yellow.
Additional file 15: Dataset S6. Predicted targets and GO
annotation of wild type and edited rno-miR-376b (A/G: 6).
Additional file 16: Dataset S7. All primers used in present study.
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